Cannabis cream for pain
Pro Research Analysisby 
Searched over 200M research papers
Cannabis Cream for Pain: A Comprehensive Review
Introduction to Cannabis-Based Pain Management
Cannabis has been utilized for medicinal purposes for centuries, particularly for its analgesic properties. With the increasing legalization and acceptance of cannabis-based products, there is a growing interest in their efficacy for pain management. This article synthesizes current research on the use of cannabis cream and other cannabis-based medicines for chronic pain relief.
Efficacy of Cannabis-Based Medicines for Chronic Pain
Systematic Reviews and Meta-Analyses
Several systematic reviews and meta-analyses have evaluated the efficacy of cannabis-based medicines (CBMs) for chronic pain. A meta-analysis of randomized controlled trials (RCTs) found that cannabis preparations showed a moderate reduction in chronic pain compared to placebo, with a standardized mean difference favoring cannabis . Another review highlighted that CBMs might be effective for chronic pain treatment, particularly for neuropathic pain, although the clinical significance of these findings remains uncertain .
Specific Findings on Pain Relief
Research indicates that cannabis-based products, including creams, can provide pain relief. For instance, a review focusing on orofacial pain found that topical cannabidiol formulations reduced pain and improved muscle function in patients with myofascial pain . Additionally, a systematic review of cannabis for chronic neuropathic pain suggested that cannabis-based medicines might increase the number of people achieving significant pain relief compared to placebo .
Adverse Effects and Safety Concerns
Common Adverse Events
While cannabis-based medicines can be effective for pain relief, they are also associated with several adverse effects. Common side effects include dizziness, sedation, and cognitive impairment McDonagh2022Wang2021. A systematic review noted that gastrointestinal adverse events were more frequent when CBMs were administered orally or via oromucosal routes compared to inhalation .
Risk of Serious Adverse Events
The potential harms of cannabis-based medicines may outweigh their benefits for some patients. Studies have reported an increased risk of serious adverse events, including nervous system and psychiatric disorders . Another review emphasized the need for comprehensive risk-benefit discussions due to the significant possible side effects of cannabis .
Variability in Product Formulations and Administration Routes
THC-to-CBD Ratios
The efficacy and safety of cannabis-based products can vary significantly depending on their THC-to-CBD ratios and the method of administration. Products with high THC-to-CBD ratios may offer moderate pain relief but are also associated with higher risks of dizziness and sedation . Conversely, sublingual sprays with comparable THC-to-CBD ratios might provide small improvements in pain severity and overall function but also carry risks of nausea and sedation .
Topical Applications
Topical cannabis creams are gaining attention for their potential to provide localized pain relief with fewer systemic side effects. However, the evidence supporting their use is still emerging, and more research is needed to substantiate their efficacy and safety .
Conclusion
Cannabis-based medicines, including creams, show promise for the management of chronic pain. While they can provide moderate pain relief, their use is often accompanied by significant adverse effects. The variability in product formulations and administration routes further complicates their efficacy and safety profiles. More high-quality, long-term studies are needed to fully understand the benefits and risks of cannabis-based treatments for pain. As the use of medical cannabis continues to rise, healthcare professionals must stay informed about the latest research to guide their patients effectively.
Sources and full results
Most relevant research papers on this topic